The current editorial team began its 3-year tenure at the Congress of the Spanish Society of Cardiology (SEC) held in Zaragoza at the end of October 2021. Now, as every year,1,2 it is time to summarize the journal's activity in the last 12 months. First, we would like to thank the editorial office (Eva M. Cardenal, María González Nogal, Helena Gómez-Lobo, and Belén Juan), led by our editorial director, Iria del Río, for their excellent professionalism in ensuring an orderly transition between teams.
EDITORIAL ACTIVITYFigure 1 shows the number of articles received in 2022. Of note, the number of submissions decreased markedly, particularly original articles and scientific letters. There is no clear explanation for this. The most plausible reason is that submissions significantly increased in the year of the COVID-19 pandemic outbreak. Indeed, Figure 1 illustrates the historical peak in the submission of original articles and scientific letters in 2020. Conceivably, research groups need new data to restart production. There were some initial signs of a recovery at the end of 2022, as shown in Figure 2. In addition, and with the aim of boosting publication activity, Rev Esp Cardiol has promoted the involvement of young cardiologists in research and publication (see below). In addition, we have decided to actively invite internationally known groups working on experimental cardiology to submit research articles to Rev Esp Cardiol. All of this, together with the journal's high impact factor (IF) in the 2021 Journal Citation Reports (2022 release), lead us to feel optimistic that submissions will increase in the near future.
Most of the articles (53%) continue to be submitted from Spain, while 13% are from other European countries, 15% from Latin America, less than 1% from North America, and 18% from other countries (mainly Asia).
THE REVIEW PROCESS AND REVIEW TIMESReviewers’ commitment to Rev Esp Cardiol is one of its main assets. The virtues of our review process are its quality and speed. Table 1 and Table 2 list Rev Esp Cardiol reviewers in 2022 and our elite reviewers (September 2021 – August 2022). We would like to extend our most sincere gratitude and appreciation to all of them. Figure 3 shows the review times of the first submitted version of the manuscripts in 2022, which are excellent and fairly similar to those of 2021. We believe that shorter times would probably be incompatible with a thorough review.
Revista Española de Cardiología reviewers in 2022
Omar Abdul-Jawad |
César Abelleira |
Emad Abu-Assi |
Juan Acosta |
Alejandro Adsuar |
Jazmín Aguado |
Finn Akerström |
Arístides Alarcón |
Alejandro Alcaine |
Manuel Alcázar |
Guillermo Aldama |
Jorge Alegre |
Josep M. Alegret |
Fernando Alfonso |
Joaquín Alonso |
Gonzalo L. Alonso-Salinas |
Pau Alonso |
Rodrigo Alonso |
Rafael Alonso-González |
Alberto Alperi |
Miguel Álvarez |
Jesús Álvarez-García |
Ignacio J. Amat |
Dominick Angiolillo |
Ignasi Anguera |
Manuel P. Anguita |
Eduardo Arana |
Miguel Á. Arias |
Albert Ariza |
Pedro Armario |
Vicente Arrarte |
Ramón Arroyo |
Dabit Arzamendi |
Juan J. Badimón |
Enrique J. Balbacid |
José Banegas |
Adrian Baranchuk |
Alfredo Bardají |
Eduardo Barge-Caballero |
Gonzalo Barge-Caballero |
José Barrabes |
Ana Barradas |
Manuel Barreiro |
Roberto Barriales |
Antonio Barros |
Teresa Bastante |
Pablo Bastos |
Javier Bautista |
Antoni Bayés de Luna |
Antoni Bayés-Genís |
Víctor Bazán |
Begoña Benito |
Alberto Berenguer |
Francisco J. Bermúdez |
J. Luis Bernal |
José R. Berrazueta |
Antonio Berruezo |
Giuseppe Biondi |
Manuel Blanco |
Zorba Blázquez |
Vicente Bodí |
Clara Bonanad |
Araceli Boraita |
Luis Borrego |
Xavier Bosch |
Ramón Bover |
Montserrat Bret |
María Brion |
Sem Briongos |
Josep Brugada |
Héctor Bueno |
Pilar Cabanas |
Ramón Calviño |
Francisco E. Calvo |
David Calvo |
Óscar Campuzano |
Raquel Campuzano |
Óscar Cano |
Victoria Cañadas |
Pedro Caravaca |
Juan Caro |
Amelia Carro |
Antonio Cartón |
Víctor Castro |
Pilar Cejudo |
Ángel R. Cequier |
Marina Cerrone |
Marinela Chaparro |
Fernando Civeira |
Marta Cobo |
Miguel Á. Cobos |
Antonio Coca |
Josep Comín |
Luciano Consuegra |
Alberto Cordero |
Juan Cosín-Sales |
Eliecer Coto |
Javier Courel |
David Couto |
Ignacio Cruz |
Héctor Cubero |
José I. Cuende |
Emilio Cuesta |
José Curbelo |
Regina Dalmau |
Tomás Datino |
José A. de Agustín |
Fernando de Frutos |
Javier De Juan Bagudá |
Rafael E. De la Espriella |
Jesus M. de la Hera |
José M. de la Torre-Hernández |
Giovanni Luigi De María |
Irene R. Dégano |
Juan F. Delgado |
Beatriz Díaz-Molina |
José F. Díaz |
Leonel Díaz-González |
Jesús Díaz-Gutiérrez |
Elena Díaz-Peláez |
Javier Díez |
Pablo Díez-Villanueva |
David Dobarro |
Adelina Doltra |
Blanca Domenech |
Fernando Domínguez |
Alberto Domínguez-Rodríguez |
Laura Dos |
Julio C. Echarte |
Sonia Eiras |
Rocío Eiros |
Jaime Elízaga |
Daniel Enríquez |
Carlos Escobar |
Laura Escolà-Vergé |
M. Pilar Escribano |
Juan M. Escudier |
Alberto Esteban |
Rodrigo Estévez |
Vicente Estrada |
Artur Evangelista |
Núria Farré |
Marta Farrero |
José A. Fernández-Díaz |
Carlos Fernández-Palomeque |
Ángel L. Fernández |
Juan Fernández-Armenta |
Leticia Fernández-Friera |
Covadonga Fernández-Golfín |
Ignacio Fernández-Lozano |
Diego Fernández-Rodríguez |
Marcos Ferrández-Escarabajal |
Ignacio Ferreira-González |
José L. Ferreiro |
Carlos Ferrera |
Xacobe Flores |
Adolfo Fontenla |
José F. Forteza |
Eduardo Franco |
Xavier Freixa |
Luigi Gabrielli |
Carlos Galán |
Laura Galián |
María Gallego-Delgado |
Ana García-Álvarez |
Bruno García del Blanco |
Alba García-Escolano |
Rocío García-Orta |
Ignacio García-Bolao |
Alberto García-Lledó |
Inés García-Lunar |
Xavier García-Moll |
Antonio García-Quintana |
José A. García-Robles |
Juan Gimeno |
Josébe Goirigolzarri-Artaza |
Dulcenombre Gómez-Garre |
M. Carmen Gómez-Rubín |
Manuel Gómez-Bueno |
Juan J. Gómez-Doblas |
Joan A. Gómez-Hospital |
José González-Costello |
Arantxa González-Miqueo |
Álvaro González-Rocafort |
José M. González-Santos |
Juan J. González-Ferrer |
Violeta González-Salvado |
Francisco González-Vílchez |
José L. Górriz |
John Graham |
Antonio Grande |
Pilar Guallar |
Eduard Guasch |
José Guerra |
Enrique Gutiérrez-Ibañes |
José Gutiérrez |
Gabriela Guzmán-Martínez |
Jordi Heijman |
Iván Hernández-Betancor |
Felipe Hernández-Hernández |
Francisco J. Hernández-Pérez |
Daniel Hernández-Vaquero |
Ignacio Iglesias-Gárriz |
José Jalife |
Santiago Jiménez-Valero |
Carmen Jiménez |
Javier Jiménez-Candil |
Juan Jiménez-Jáimez |
Manuel F. Jiménez-Navarro |
Justo Juliá |
Alfonso Jurado-Román |
Juan C. Kaski |
Adnan Kastrati |
Won-Keun Kim |
Giulio La Rosa |
Enrique Lara |
María Lázaro |
Pablo Loma-Osorio |
Teresa López-Fernández |
José López-Haldón |
Diego López-Otero |
Javier López |
Esteban López-de-Sá |
Ramón López-Palop |
Rebeca Lorca |
Gerard Loughlin |
Íñigo Lozano |
María Luaces |
Álvaro Macías |
Begoña Manso |
Francisco Marín |
Manuel Marina |
Manlio F. Márquez |
Carlos E. Martín |
María Martín |
Laura Martínez-Mateu |
Pedro Martínez |
Isaac Martínez-Bendayán |
José L. Martínez-Sande |
Manuel Martínez-Sellés |
Lluis Masana |
María D. Masiá |
Andrea Mazzanti |
Hernán D. Mejía |
Ana Méndez |
Irene Méndez |
Guiomar Mendieta |
Dolores Mesa-Rubio |
Ángel L. Miracle |
Javier Modrego |
Pedro Moliner |
Emilio Monguió |
Lorenzo Monserrat |
Juan M. Monteagudo |
Vanessa Moñivas |
Raúl Moreno |
César Morís |
Guillermo Muñiz |
Antonio J. Muñoz |
José Nativi |
Luis Nombela |
Francisco J. Noriega |
Julio Núñez |
Iván J. Núñez-Gil |
Soledad Ojeda |
Carmen Olmos |
Peter Ong |
Marta Ortega |
Carolina Ortiz |
Joaquín Osca |
Teresa Padró |
Julián Palacios |
Julián Palomino |
Manuel Pan |
Ana Pardo |
Isaac Pascual |
Salvador Pedraza |
Rafael Peinado |
Laura Peña |
María L. Peña |
Daniel Pereda |
Leopoldo Pérez de Isla |
Armando Pérez de Prado |
Diego Pérez |
Esther Pérez-David |
Carlos N. Pérez-García |
Antonia Pijuan |
Inés Ponz de Antonio |
Eduardo Pozo |
Raquel Prieto |
Juan Puig |
Juan Quiles |
Antonio Ramos-Martínez |
Diego Rangel |
Sergio Raposeiras-Roubín |
Susana Ravassa |
Elena Refoyo |
Ander Regueiro |
María A. Restrepo |
Juan R. Rey |
Juan J. Ríos |
Tomás Ripoll |
Mercedes Rivas |
José Rivera |
Fernando Rivero |
Ivo Roca-Luque |
Moisés Rodríguez-Mañero |
José F. Rodríguez-Palomares |
Inmaculada Roldán |
Nieves Romero |
José Rozado |
Fernando Rueda |
José Ruiz-Cantador |
Ricardo Ruiz-Granell |
María J. Ruiz-Cano |
Juan M. Ruiz-Nodar |
Manel Sabaté |
Ricardo Salgado |
Rafael Salguero |
Luisa Salido |
Jorge Salinas |
Pablo Salinas |
Óscar Salvador |
José A. San Román |
Pedro L. Sánchez |
Javier Sánchez-González |
Ángel Sánchez-Recalde |
Enrique Santas |
Carlos García Santos-Gallego |
María Sanz de la Garza |
Javier Sanz |
Fernando Sarnago |
Georgia Sarquella |
Inés Sayago |
Javier Segovia |
Lorenzo Silva |
Jacobo Silva |
Alessandro Sionis |
Marta Sitges |
Maite Subirana |
Gabriela Tirado |
Jorge Toquero |
Javier Torres |
Leire Unzué |
Aitor Uribarri |
Félix Valencia |
Alfonso Valle |
Israel Valverde |
Luca Vannini |
Ravi Vazirani |
Rafael Vázquez-García |
Ana Viana |
Rafael Vidal |
Maite Vidán |
Isidre Vilacosta |
Ricardo Vivancos |
David Vivas |
Sergi Yun |
Juan I. Zabala |
Elisabet Zamora |
Manuel Zarzoso |
Eduardo Zatarain |
Newsletters have become central for readers of scientific journals. Currently, they are the primary vehicle for spreading newly published articles. With this in mind, we have completely renewed Rev Esp Cardiol newsletters as follows: a) the content is separated according to the language of the articles, with English at the top of the newsletter and Spanish at the bottom; thus, readers can directly access their preferred language; b) articles are classified and grouped according to their specific field, identified by a section heading; c) a central illustration is included for each original, review and special article; d) the number of listed authors per article has been reduced to two (first and last) to avoid a wordy presentation; and e) the header Rev Esp Cardiol is now more visible.
The first revamped newsletter was sent to our subscribers on April 26, 2022. The initial feedback was fairly positive as per the number of articles downloaded, with a significant and sustained increase.
Central illustrationMany journals have now introduced a central illustration in original articles. The goal is to show the main result of the study in a graphic and appealing design. Rev Esp Cardiol joined this trend in 2022, presenting central illustrations in the newsletter and website. We hope our readers find this initiative attractive.
Mean time between acceptance and publicationAuthors appreciate speed between acceptance of their articles and their availability in Medline. In addition, knowledge is disseminated to the scientific community earlier. So far, the first format through which Rev Esp Cardiol articles could be accessed via Medline was the ahead-of-print publication of the English version. The production of an ahead-of-print article takes around 40 days. Despite the efforts of our editorial office and publisher, we were unable to shorten this production time and so we took the initiative of producing an uncorrected version of our articles (pre-proof) immediately after their acceptance. Overall, this format makes articles available approximately 17 days after acceptance on the Rev Esp Cardiol website and ScienceDirect and about 14 days later on Medline. This does not apply to articles submitted in Spanish, since Medline only indexes the English edition of Rev Esp Cardiol. Consequently, articles submitted in Spanish must wait for their English translation for publication on Medline.
Education and young cardiologistsA central objective of scientific journals should be education, which should not be overshadowed by bibliometric interests. Indeed, we have continued and increased the publication of reviews and consensus documents considered of interest to the cardiology community3–13 and the official reports of the national registries of pacemakers,14 implantable automatic defibrillators,15 heart transplant,16 cardiac catheterization and interventional cardiology,17 and catheter ablation.18 Starting this year, the translated version of the ESC guidelines will be available on the SEC website rather than in Rev Esp Cardiol.
The editorial team believes that it is essential to involve young cardiologists in research. To this end, we created 2 new awards for the best articles published in Rev Esp Cardiol by a cardiologist of 40 years or younger and a resident in addition to the annual SEC awards for the best published articles (Table 3). Likewise, at the 2022 SEC Congress held in Palma de Mallorca, the editors delivered a seminar on designing and conducting a research project and writing a scientific article. In addition, in 2022 Rev Esp Cardiol published the best clinical case of the 2022 SEC Clinical Case League in the form of a scientific letter, accompanied by an editorial comment emphasizing its educational value.39,40Rev Esp Cardiol is now preparing the 2023 edition. We hope that all these initiatives will increae awareness among young cardiologists and residents of the importance of research.
Articles receiving an award from the Spanish Society of Cardiology in 2022
1. Prizes awarded by the Spanish Society of Cardiology for articles published in Rev Esp Cardiol in 2021 |
First prize |
Morentin B, et al. Sports-related sudden cardiac death in Spain. A multicenter, population-based, forensic study of 288 cases. Rev Esp Cardiol. 202119 |
Second prize |
Barriales-Villa R, et al. Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry. Rev Esp Cardiol. 202120 |
2. Prizes awarded by the Spanish Society of Cardiology for the articles published in Rev Esp Cardiol with the greatest international impact |
Most-cited articles, long-term |
First prize |
Aranceta-Bartrina J, et al. Prevalence of General Obesity and Abdominal Obesity in the Spanish Adult Population (Aged 25–64 Years) 2014–2015: The ENPE Study. Rev Esp Cardiol. 201621 |
Second prize |
Menéndez E, et al. Prevalence, Diagnosis, Treatment, and Control of Hypertension in Spain. Results of the Di@bet.es Study. Rev Esp Cardiol. 201622 |
Most-cited articles, midterm |
First prize |
Hernaez A, et al. Excess Weight in Spain: Current Situation, Projections for 2030, and Estimated Direct Extra Cost for the Spanish Health System. Rev Esp Cardiol. 2019.23 |
Second prize |
Na SJ, et al. Vasoactive Inotropic Score as a Predictor of Mortality in Adult Patients With Cardiogenic Shock: Medical Therapy Versus ECMO. Rev Esp Cardiol. 2019.24 |
3. Prize awarded by the Spanish Society of Cardiology for the best article published in Rev Esp Cardiol by a first author ≤ 40 years old |
López - Sainz A, et al. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center. Rev Esp Cardiol. 202125 |
4. Prize awarded by the Spanish Society of Cardiology for the best article published in Rev Esp Cardiol by a resident in a Spanish center |
Sánchez Vega JD, et al. Temporal trends in postinfarction ventricular septal rupture: the CIVIAM Registry. Rev Esp Cardiol. 202126 |
5. Prize awarded by the Spanish Society of Cardiology for the best article published in REC: CardioClinics |
Plata-Mosquera CA, et al. Sacubitril/valsartan reduces levels of procollagen types I and III and correlates with reverse cardiac remodeling. REC CardioClinics. 202127 |
6. Prize awarded by the Interventional Cardiology Association for the best article published in REC: Interventional Cardiology |
First prize |
van Zandvoort LJC, et al. Predictors of postprocedural fractional flow reserve: insights from the FFR-SEARCH study. REC Interv Cardiol. 202128 |
Second prize |
Cepas-Guillén PL, et al. Outcomes of nonagenarians after transcatheter aortic valve implantation. REC Interv Cardiol. 202129 |
7. Prizes awarded by the Clinical Cardiology Association for the best articles published in Rev Esp Cardiol |
López-Sainz A, et al. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center. Rev Esp Cardiol. 202125 |
Martín García A, et al. Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC. Rev Esp Cardiol. 202130 |
8. Prize awarded by the Ischemic Heart Disease and Acute Cardiac Care Association for the best article published in Rev Esp Cardiol |
Sánchez-Salado JC, et al. Trends in cardiogenic shock management and prognostic impact of type of treating center. Rev Esp Cardiol. 202031 |
9. Prize awarded by the Cardiovascular Risk and Rehabilitation Association for the best publication |
Castro-Conde A, et al. Feasibility and results of an intensive cardiac rehabilitation program. Insights from the MxM (Más por Menos) randomized trial. Rev Esp Cardiol. 202132 |
10. Prize awarded by the Heart Rhythm Association for the best article published in Rev Esp Cardiol |
Loughlin G, et al. Predictors of adoption and impact of evidence-based programming on the incidence of implantable cardioverter-defibrillator therapies. Rev Esp Cardiol. 202133 |
11. Prize awarded by the Pediatric Cardiology and Congenital Heart Disease Section for the best article published in Rev Esp Cardiol |
Rueda Soriano J, et al. Time course and predictors for neoaortic root dilatation and neoaortic valve regurgitation during adult life after arterial switch operation. Rev Esp Cardiol. 202134 |
12. Prize awarded by the Section on Familial Heart Disease and Cardiovascular Genetics for the best article published in Rev Esp Cardiol |
Barriales-Villa R, et al. Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry. Rev Esp Cardiol. 202120 |
13. Prizes awarded by the Cardiac Imaging Association for the best articles published |
Gamaza S, et al. Prognostic value of aortic valve area normalized to body size in native aortic stenosis. Rev Esp Cardiol. 202135 |
Urmeneta J, et al. Myocardial strain in nonischemic dilated cardiomyopathy with feature tracking. Feasibility and prognostic implications. Rev Esp Cardiol. 202136 |
14. Magda Heras prize for the best article published in an Iberoamerican cardiovascular journal |
First prize |
Morentin B, et al. Sports-related sudden cardiac death in Spain. A multicenter, population-based, forensic study of 288 cases. Rev Esp Cardiol. 202119 |
Second prize |
Santos IS, et al. Atrial Fibrillation Diagnosis using ECG Records and Self-Report in the Community: Cross-Sectional Analysis from Elsa-Brasil. Arq Bras Cardiol. 202137 |
Third prize |
Jimena Gamgarte M, et al. Comparación pronóstica entre scores de riesgo y la aplicación de redes neuronales para la predicción de la mortalidad a corto y mediano plazo en pacientes con insuficiencia cardiaca. Rev Argent Cardiol. 202138 |
Our website is an undisputed reference for information on cardiology in Spanish.41 In 2022, our digital edition was consulted by more than 5.7 million users, with a total of almost 13 million page views. In ScienceDirect, Rev Esp Cardiol articles exceeded 1 million visits to our Spanish and English articles. There were also the views and downloads from other repositories. Most of the traffic comes from the prominent positioning of our articles in search engines (91.4% organic traffic), followed by direct searches and links from other websites.
During the last year, we have been intensely active on social media, mainly on Twitter, the preferred social platform of cardiologists worldwide. The number of followers of the REC Publications Twitter profile42 has increased (20 380 at the beginning of 2023), and efforts have been made to tag article authors, who now also have the possibility of including their Twitter account information in their articles. Last year, we incorporated the creation of threads and increased our multimedia content, with central illustrations to make the articles more attractive to read and enhance their dissemination. We would like to thank the REC Publications’ ICT consultant, Juan Quiles, for his excellent work.
Starting in 2023, there have been some notable innovations regarding the Editor's videos: they have been shortened to 2minutes and, instead of the previous author-editor interview, one of the authors now takes on the leading role, directly presenting the main findings of the research article. Our idea is to facilitate views on mobile devices and social media and optimize the integration of these materials in CardioTV, the audiovisual SEC ecosystem. Rev Esp Cardiol will continue the regular publication of author interviews on the Rev Esp Cardiol Blog,43 on the SEC website and their presence in SEC News and other SEC bulletins.
RegistriesRegistries are an essential source of research activity. They often involve multiple centers and patients. Consequently, coordination and data management require considerable effort by principal investigators and these articles deserve publication of the results in a top journal like Rev Esp Cardiol. For this purpose, proper design and high-quality data are essential. In a recent Editor's page, we expressed concerns about self-reported, unaudited registries submitted to Rev Esp Cardiol.44 In summary, our thoughts are as follows: a) a registry should address not only what is already known in a particular context but also some novel features; b) the availability of electronic clinical histories allows homogeneity of data acquisition among centers, in terms of a reproducible flowchart for screening and recruitment, and facilitates follow-up.45 Therefore, the final article should present a flowchart and the completeness of the follow-up. Furthermore, these articles will now have to include information on participating centers, listing the principal investigator in each center who is responsible for the accuracy of the data.
BIBLIOMETRIC NEWSIF is often considered the universal quality index of scientific journals. Rev Esp Cardiol reached its historical IF peak last year, positioning the journal in the first quartile of the Cardiac and Cardiovascular Systems category. We acknowledge the excellent job of the previous editorial team. Without denying its value as the first marker of a scientific journal, IF is widely recognized to be an imperfect metric.46 This index can be increased or decreased by unexpected circumstances. Furthermore, the system for measuring IF is changing, and, starting in 2020, early access is gradually being added to Journal Citation Reports. This onboarding process is not simultaneous for all journals and, until it finishes, which may take years, IF may become unstable. We are paying close attention to changes in the IF of Rev Esp Cardiol without forgetting other quality indexes or the journal's educational objectives.
FUTURE OF REV ESP CARDIOLIn 2022 we celebrated 75 years of Rev Esp Cardiol, providing us with an opportunity to reflect on what has been achieved during these years and the future of the journal. The scenario of cardiology journals has become highly competitive. The leading journals have created an extensive network of excellent family journals, while new journals, mostly open-access, have also been launched. Traditional journals face difficulties in jostling for a space in this highly competitive field. The situation is even more challenging for national journals like Rev Esp Cardiol. We created our sister journals (REC: CardioClinics47 and REC: Interventional Cardiology48) in 2018 to allow the publication of more submitted articles. We also have an international mission, and some initiatives this year went in this direction. However, Spanish investigators constitute our primary target. They are the main asset of Rev Esp Cardiol, and their contribution is essential for the future. From these lines, we would like to encourage them to continue supporting Rev Esp Cardiol, and our commitment is to respond to this engagement.
FUNDINGNone received.
CONFLICTS OF INTERESTNone declared.
Once again, we must mention the work of the translation and proofreading teams, whose professionalism allows the journal to continue to be bilingual. For the English version, we continue to count on the translation team composed of Simon Bartlett, Helen Casas, Celine Cavallo, Kevin Clayton, Simon Coxon, Jane Marshall, and Anne Murray, coordinated by Gail Craigie as copyeditor. We also thank all the departments of Casa del Corazón for their help and support in increasing the prominence of our journal; José Luis Vázquez, responsible for audiovisuals at the SEC, deserves special mention for his enthusiasm and professionalism in new Rev Esp Cardiol projects, as does Fernando Fernández, director of the IT department, for his collaborative vision and valuable insights.
Finally, we would like to dedicate this article to our beloved Azucena Saavedra, our journal manager in Elsevier since 2017, whose loss in December 2022 filled us with sadness. May these lines serve to thank her for her great work, which has been instrumental in helping our journal to achieve many successes over the years, including those presented on this Editors’ Page.